Atlas Trials

Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)

Clinical trial NCT02705859 · COMPLETED

Trial details

NCT number
NCT02705859
Sponsor
Cancer Trials Ireland
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2 Positive Breast Cancer
Start date
2016-04-01
Primary completion
2021-05-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.